Proactive Investors
05 Oct 2026, 11:34 UTC · 1h ago
Burberry valuation still understates recovery potential, says UBS
Impact · against what's priced in
Burberry's outlook is boosted by specific H1 earnings and sales forecasts that suggest a sharper immediate recovery than consensus expectations. Galliford Try sees a modest positive catalyst from securing a spot on a major £3 billion regional framework.
- BRBY+0.50
No priced-in read yet
- In context
UBS forecasts H1 sales of £1.087 billion and a 105% increase in EBIT to £39 million, providing concrete short-term targets ahead of the November 12 results.
Read from the article alone
